 | | RHG | | Name: | (3aR,8S,9aS)-2-[(trifluoromethyl)sulfonyl]decahydro-3a,8-epoxypyrrolo[3,4-c]azocine | | Formula: | C10 H15 F3 N2 O3 S | | SMILES: | C2NCC13C(CN(C1)S(C(F)(F)F)(=O)=O)CC(C2)O3 | | InChi: | InChI=1S/C10H15F3N2O3S/c11-10(12,13)19(16,17)15-4-7-3-8-1-2-14-5-9(7,6-15)18-8/h7-8,14H,1-6H2/t7-,8+,9+/m0/s1 | | Definition date: | 2020-02-12 | | Last modified: | 2020-04-03 | | Release date: | 2020-04-08 | | Identifier: | (3aR,8S,9aS)-2-[(trifluoromethyl)sulfonyl]decahydro-3a,8-epoxypyrrolo[3,4-c]azocine |
|
 | | RHV | | Name: | ethyl N-[(2R)-2-(4-methylpyridin-2-yl)propanoyl]glycinate | | Formula: | C13 H18 N2 O3 | | SMILES: | C(C(NCC(OCC)=O)=O)(C)c1cc(C)ccn1 | | InChi: | InChI=1S/C13H18N2O3/c1-4-18-12(16)8-15-13(17)10(3)11-7-9(2)5-6-14-11/h5-7,10H,4,8H2,1-3H3,(H,15,17)/t10-/m1/s1 | | Definition date: | 2020-02-12 | | Last modified: | 2020-04-03 | | Release date: | 2020-04-08 | | Identifier: | ethyl N-[(2R)-2-(4-methylpyridin-2-yl)propanoyl]glycinate |
|
 | | QPV | | Name: | 3-chloro-N-{4-[1-(propylcarbamoyl)cyclobutyl]phenyl}benzamide | | Formula: | C21 H23 Cl N2 O2 | | SMILES: | C(C3(c1ccc(cc1)NC(c2cccc(c2)Cl)=O)CCC3)(NCCC)=O | | InChi: | InChI=1S/C21H23ClN2O2/c1-2-13-23-20(26)21(11-4-12-21)16-7-9-18(10-8-16)24-19(25)15-5-3-6-17(22)14-15/h3,5-10,14H,2,4,11-13H2,1H3,(H,23,26)(H,24,25) | | Definition date: | 2019-12-06 | | Last modified: | 2020-04-03 | | Release date: | 2020-04-08 | | Identifier: | 3-chloro-N-{4-[1-(propylcarbamoyl)cyclobutyl]phenyl}benzamide |
|
 | | RHY | | Name: | 1-[(4aS,7aS,9S)-3,4,7,7a,8,9-hexahydro-4a,9-epoxypyrrolo[3',4':4,5]cyclohepta[1,2-d]imidazol-6(5H)-yl]ethan-1-one | | Formula: | C12 H15 N3 O2 | | SMILES: | C321Cc4c(C(CC1CN(C2)C(C)=O)O3)ncn4 | | InChi: | InChI=1S/C12H15N3O2/c1-7(16)15-4-8-2-10-11-9(13-6-14-11)3-12(8,5-15)17-10/h6,8,10H,2-5H2,1H3,(H,13,14)/t8-,10-,12+/m0/s1 | | Definition date: | 2020-02-12 | | Last modified: | 2020-04-03 | | Release date: | 2020-04-08 | | Identifier: | 1-[(4aS,7aS,9S)-3,4,7,7a,8,9-hexahydro-4a,9-epoxypyrrolo[3',4':4,5]cyclohepta[1,2-d]imidazol-6(5H)-yl]ethan-1-one |
|
 | | RJ4 | | Name: | (4aR,7aR,9R)-3,4,7,7a,8,9-hexahydro-4a,9-epoxypyrrolo[3',4':4,5]cyclohepta[1,2-d]imidazole-6(5H)-carbaldehyde | | Formula: | C11 H13 N3 O2 | | SMILES: | O=CN1C[CH]2C[CH]3O[C]2(C1)Cc4[nH]cnc34 | | InChi: | InChI=1S/C11H13N3O2/c15-6-14-3-7-1-9-10-8(12-5-13-10)2-11(7,4-14)16-9/h5-7,9H,1-4H2,(H,12,13)/t7-,9-,11+/m1/s1 | | Definition date: | 2020-02-12 | | Last modified: | 2020-04-03 | | Release date: | 2020-04-08 |
|
 | | RJD | | Name: | (3S,6S)-N~3~-cyclopropyl-N~1~-(cyclopropylmethyl)-3,6-dimethylpiperazine-1,3-dicarboxamide | | Formula: | C15 H26 N4 O2 | | SMILES: | C1(CC1)NC(C3(CN(C(NCC2CC2)=O)C(C)CN3)C)=O | | InChi: | InChI=1S/C15H26N4O2/c1-10-7-17-15(2,13(20)18-12-5-6-12)9-19(10)14(21)16-8-11-3-4-11/h10-12,17H,3-9H2,1-2H3,(H,16,21)(H,18,20)/t10-,15-/m0/s1 | | Definition date: | 2020-02-12 | | Last modified: | 2020-04-03 | | Release date: | 2020-04-08 | | Identifier: | (3S,6S)-N~3~-cyclopropyl-N~1~-(cyclopropylmethyl)-3,6-dimethylpiperazine-1,3-dicarboxamide |
|
 | | RJG | | Name: | (3aR,10R,10aR,11aR)-1,2,3,5,10,10a,11,11a-octahydro-3a,10-ethanopyrrolo[3',4':4,5]pyrrolo[1,2-b]isoquinolin-13-one | | Formula: | C16 H18 N2 O | | SMILES: | N13C5CC2CNCC12C(CC5c4c(C3)cccc4)=O | | InChi: | InChI=1S/C16H18N2O/c19-15-6-13-12-4-2-1-3-10(12)8-18-14(13)5-11-7-17-9-16(11,15)18/h1-4,11,13-14,17H,5-9H2/t11-,13-,14-,16+/m1/s1 | | Definition date: | 2020-02-12 | | Last modified: | 2020-04-03 | | Release date: | 2020-04-08 | | Identifier: | (3aR,10R,10aR,11aR)-1,2,3,5,10,10a,11,11a-octahydro-3a,10-ethanopyrrolo[3',4':4,5]pyrrolo[1,2-b]isoquinolin-13-one |
|
 | | RJJ | | Name: | (5R)-N-benzyl-5-ethyl-1-methyl-1,4-diazepane-5-carboxamide | | Formula: | C16 H25 N3 O | | SMILES: | c1cc(ccc1)CNC(C2(CC)CCN(C)CCN2)=O | | InChi: | InChI=1S/C16H25N3O/c1-3-16(9-11-19(2)12-10-18-16)15(20)17-13-14-7-5-4-6-8-14/h4-8,18H,3,9-13H2,1-2H3,(H,17,20)/t16-/m1/s1 | | Definition date: | 2020-02-12 | | Last modified: | 2020-04-03 | | Release date: | 2020-04-08 | | Identifier: | (5R)-N-benzyl-5-ethyl-1-methyl-1,4-diazepane-5-carboxamide |
|
 | | RK1 | | Name: | (7R)-N-benzyl-1,7-diethyl-2,3,6,7-tetrahydro-1H-1,4-diazepine-7-carboxamide | | Formula: | C17 H25 N3 O | | SMILES: | C(C1(CC=NCCN1CC)C(=O)NCc2ccccc2)C | | InChi: | InChI=1S/C17H25N3O/c1-3-17(10-11-18-12-13-20(17)4-2)16(21)19-14-15-8-6-5-7-9-15/h5-9,11H,3-4,10,12-14H2,1-2H3,(H,19,21)/t17-/m1/s1 | | Definition date: | 2020-02-13 | | Last modified: | 2020-04-03 | | Release date: | 2020-04-08 | | Identifier: | (7R)-N-benzyl-1,7-diethyl-2,3,6,7-tetrahydro-1H-1,4-diazepine-7-carboxamide |
|
 | | RKG | | Name: | methyl (4aS,7aS,9S)-3,4,7,7a,8,9-hexahydro-4a,9-epoxypyrrolo[3',4':4,5]cyclohepta[1,2-d]imidazole-6(5H)-carboxylate | | Formula: | C12 H15 N3 O3 | | SMILES: | C3C21C(CN(C(OC)=O)C1)CC(O2)c4c3ncn4 | | InChi: | InChI=1S/C12H15N3O3/c1-17-11(16)15-4-7-2-9-10-8(13-6-14-10)3-12(7,5-15)18-9/h6-7,9H,2-5H2,1H3,(H,13,14)/t7-,9-,12+/m0/s1 | | Definition date: | 2020-02-13 | | Last modified: | 2020-04-03 | | Release date: | 2020-04-08 | | Identifier: | methyl (4aS,7aS,9S)-3,4,7,7a,8,9-hexahydro-4a,9-epoxypyrrolo[3',4':4,5]cyclohepta[1,2-d]imidazole-6(5H)-carboxylate |
|
 | | RKJ | | Name: | (4R,4aS,7aS,9S)-6-ethyl-3,10-dimethyl-5,6,7,7a,8,9-hexahydro-4H-4a,9-epiminopyrrolo[3',4':5,6]cyclohepta[1,2-d][1,2]oxazol-4-ol | | Formula: | C14 H21 N3 O2 | | SMILES: | N1(C3c4onc(C)c4C(C12C(CN(C2)CC)C3)O)C | | InChi: | InChI=1S/C14H21N3O2/c1-4-17-6-9-5-10-12-11(8(2)15-19-12)13(18)14(9,7-17)16(10)3/h9-10,13,18H,4-7H2,1-3H3/t9-,10-,13+,14+/m0/s1 | | Definition date: | 2020-02-13 | | Last modified: | 2020-04-03 | | Release date: | 2020-04-08 | | Identifier: | (4R,4aS,7aS,9S)-6-ethyl-3,10-dimethyl-5,6,7,7a,8,9-hexahydro-4H-4a,9-epiminopyrrolo[3',4':5,6]cyclohepta[1,2-d][1,2]oxazol-4-ol |
|
 | | TQS | | Name: | (4R,4aR,7aS,9R)-3,10-dimethyl-5,6,7,7a,8,9-hexahydro-4H-4a,9-epiminopyrrolo[3',4':5,6]cyclohepta[1,2-d][1,2]oxazol-4-ol | | Formula: | C12 H17 N3 O2 | | SMILES: | N2(C13C(CNC1)CC2c4c(C3O)c(no4)C)C | | InChi: | InChI=1S/C12H17N3O2/c1-6-9-10(17-14-6)8-3-7-4-13-5-12(7,11(9)16)15(8)2/h7-8,11,13,16H,3-5H2,1-2H3/t7-,8+,11+,12-/m0/s1 | | Definition date: | 2020-03-30 | | Last modified: | 2020-04-03 | | Release date: | 2020-04-08 | | Identifier: | (4R,4aR,7aS,9R)-3,10-dimethyl-5,6,7,7a,8,9-hexahydro-4H-4a,9-epiminopyrrolo[3',4':5,6]cyclohepta[1,2-d][1,2]oxazol-4-ol |
|
 | | D4O | | Name: | (3~{S})-3-[[(1~{S},3~{S})-3-methylcyclohexyl]methyl]-6,8-bis(oxidanyl)-3,4-dihydroisochromen-1-one | | Formula: | C17 H22 O4 | | SMILES: | C[CH]1CCC[CH](C1)C[CH]2Cc3cc(O)cc(O)c3C(=O)O2 | | InChi: | InChI=1S/C17H22O4/c1-10-3-2-4-11(5-10)6-14-8-12-7-13(18)9-15(19)16(12)17(20)21-14/h7,9-11,14,18-19H,2-6,8H2,1H3/t10-,11-,14-/m0/s1 | | Definition date: | 2019-06-27 | | Last modified: | 2020-04-03 | | Release date: | 2020-04-08 | | Identifier: | (3~{S})-3-[[(1~{S},3~{S})-3-methylcyclohexyl]methyl]-6,8-bis(oxidanyl)-3,4-dihydroisochromen-1-one |
|
 | | D4U | | Name: | (3~{S})-3-(cyclohexylmethyl)-6,8-bis(oxidanyl)-3,4-dihydroisochromen-1-one | | Formula: | C16 H20 O4 | | SMILES: | Oc1cc(O)c2C(=O)O[CH](CC3CCCCC3)Cc2c1 | | InChi: | InChI=1S/C16H20O4/c17-12-7-11-8-13(6-10-4-2-1-3-5-10)20-16(19)15(11)14(18)9-12/h7,9-10,13,17-18H,1-6,8H2/t13-/m0/s1 | | Definition date: | 2019-06-28 | | Last modified: | 2020-04-03 | | Release date: | 2020-04-08 | | Identifier: | (3~{S})-3-(cyclohexylmethyl)-6,8-bis(oxidanyl)-3,4-dihydroisochromen-1-one |
|
 | | D4X | | Name: | (3~{S})-3-[[(1~{S},3~{S})-3-methylcyclohexyl]methyl]-6,8-bis(oxidanyl)-3,4-dihydro-2~{H}-isoquinolin-1-one | | Formula: | C17 H23 N O3 | | SMILES: | C[CH]1CCC[CH](C1)C[CH]2Cc3cc(O)cc(O)c3C(=O)N2 | | InChi: | InChI=1S/C17H23NO3/c1-10-3-2-4-11(5-10)6-13-7-12-8-14(19)9-15(20)16(12)17(21)18-13/h8-11,13,19-20H,2-7H2,1H3,(H,18,21)/t10-,11-,13-/m0/s1 | | Definition date: | 2019-07-03 | | Last modified: | 2020-04-03 | | Release date: | 2020-04-08 | | Identifier: | (3~{S})-3-[[(1~{S},3~{S})-3-methylcyclohexyl]methyl]-6,8-bis(oxidanyl)-3,4-dihydro-2~{H}-isoquinolin-1-one |
|
 | | R1V | | Name: | N-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-L-glutamic acid | | Formula: | C15 H25 N O4 | | SMILES: | CC(C)=[C@H]CCC(C)=[C@H]CNC(C(O)=O)CCC(=O)O | | InChi: | InChI=1S/C15H25NO4/c1-11(2)5-4-6-12(3)9-10-16-13(15(19)20)7-8-14(17)18/h5,9,13,16H,4,6-8,10H2,1-3H3,(H,17,18)(H,19,20)/b12-9+/t13-/m0/s1 | | Definition date: | 2020-01-23 | | Last modified: | 2020-04-03 | | Release date: | 2020-04-08 | | Identifier: | N-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-L-glutamic acid |
|
 | | D5F | | Name: | 3-[[(1~{S},3~{S})-3-methylcyclohexyl]methyl]-6,8-bis(oxidanyl)isochromen-1-one | | Formula: | C17 H20 O4 | | SMILES: | C[CH]1CCC[CH](C1)CC2=Cc3cc(O)cc(O)c3C(=O)O2 | | InChi: | InChI=1S/C17H20O4/c1-10-3-2-4-11(5-10)6-14-8-12-7-13(18)9-15(19)16(12)17(20)21-14/h7-11,18-19H,2-6H2,1H3/t10-,11-/m0/s1 | | Definition date: | 2019-07-03 | | Last modified: | 2020-04-03 | | Release date: | 2020-04-08 | | Identifier: | 3-[[(1~{S},3~{S})-3-methylcyclohexyl]methyl]-6,8-bis(oxidanyl)isochromen-1-one |
|
 | | D5O | | Name: | 3-(cyclohexylmethyl)-6,8-bis(oxidanyl)isochromen-1-one | | Formula: | C16 H18 O4 | | SMILES: | Oc1cc(O)c2C(=O)OC(=Cc2c1)CC3CCCCC3 | | InChi: | InChI=1S/C16H18O4/c17-12-7-11-8-13(6-10-4-2-1-3-5-10)20-16(19)15(11)14(18)9-12/h7-10,17-18H,1-6H2 | | Definition date: | 2019-07-03 | | Last modified: | 2020-04-03 | | Release date: | 2020-04-08 | | Identifier: | 3-(cyclohexylmethyl)-6,8-bis(oxidanyl)isochromen-1-one |
|
 | | R4S | | Name: | N-[(1S,5R)-3-(5-fluoro-2-{[1-(2-hydroxyethyl)-1H-pyrazol-4-yl]amino}pyrimidin-4-yl)-3-azabicyclo[3.1.0]hexan-1-yl]cyclopropanecarboxamide | | Formula: | C18 H22 F N7 O2 | | SMILES: | n1cc(cn1CCO)Nc2ncc(c(n2)N3CC4C(C3)(C4)NC(C5CC5)=O)F | | InChi: | InChI=1S/C18H22FN7O2/c19-14-7-20-17(22-13-6-21-26(9-13)3-4-27)23-15(14)25-8-12-5-18(12,10-25)24-16(28)11-1-2-11/h6-7,9,11-12,27H,1-5,8,10H2,(H,24,28)(H,20,22,23)/t12-,18-/m1/s1 | | Definition date: | 2020-01-30 | | Last modified: | 2020-04-03 | | Release date: | 2020-04-08 | | Identifier: | N-[(1S,5R)-3-(5-fluoro-2-{[1-(2-hydroxyethyl)-1H-pyrazol-4-yl]amino}pyrimidin-4-yl)-3-azabicyclo[3.1.0]hexan-1-yl]cyclopropanecarboxamide |
|
 | | R4V | | Name: | (1S)-2,2-difluoro-N-[(1S,5R,6R)-3-{5-fluoro-2-[(1-methyl-1H-pyrazol-4-yl)amino]pyrimidin-4-yl}-6-methyl-3-azabicyclo[3.1.0]hexan-1-yl]cyclopropane-1-carboxamide | | Formula: | C18 H20 F3 N7 O | | SMILES: | n1c(ncc(c1N3CC2C(C2C)(C3)NC(C4C(F)(C4)F)=O)F)Nc5cn(nc5)C | | InChi: | InChI=1S/C18H20F3N7O/c1-9-12-7-28(8-17(9,12)26-15(29)11-3-18(11,20)21)14-13(19)5-22-16(25-14)24-10-4-23-27(2)6-10/h4-6,9,11-12H,3,7-8H2,1-2H3,(H,26,29)(H,22,24,25)/t9-,11+,12+,17+/m1/s1 | | Definition date: | 2020-01-30 | | Last modified: | 2020-04-03 | | Release date: | 2020-04-08 | | Identifier: | (1S)-2,2-difluoro-N-[(1S,5R,6R)-3-{5-fluoro-2-[(1-methyl-1H-pyrazol-4-yl)amino]pyrimidin-4-yl}-6-methyl-3-azabicyclo[3.1.0]hexan-1-yl]cyclopropane-1-carboxamide |
|
 | | R4Y | | Name: | (1S,2S)-2-cyano-N-[(1S,5R)-3-(5-fluoro-2-{[1-(2-hydroxyethyl)-1H-pyrazol-4-yl]amino}pyrimidin-4-yl)-3-azabicyclo[3.1.0]hexan-1-yl]cyclopropane-1-carboxamide | | Formula: | C19 H21 F N8 O2 | | SMILES: | N(c1cnn(CCO)c1)c2nc(c(cn2)F)N4CC3C(C3)(C4)NC(C5C(C#N)C5)=O | | InChi: | InChI=1S/C19H21FN8O2/c20-15-7-22-18(24-13-6-23-28(9-13)1-2-29)25-16(15)27-8-12-4-19(12,10-27)26-17(30)14-3-11(14)5-21/h6-7,9,11-12,14,29H,1-4,8,10H2,(H,26,30)(H,22,24,25)/t11-,12-,14+,19-/m1/s1 | | Definition date: | 2020-01-30 | | Last modified: | 2020-04-03 | | Release date: | 2020-04-08 | | Identifier: | (1S,2S)-2-cyano-N-[(1S,5R)-3-(5-fluoro-2-{[1-(2-hydroxyethyl)-1H-pyrazol-4-yl]amino}pyrimidin-4-yl)-3-azabicyclo[3.1.0]hexan-1-yl]cyclopropane-1-carboxamide |
|
 | | R5D | | Name: | (1R,2R)-2-cyano-N-[(1S,5R)-3-(5-fluoro-2-{[1-(2-hydroxyethyl)-1H-pyrazol-4-yl]amino}pyrimidin-4-yl)-3-azabicyclo[3.1.0]hexan-1-yl]cyclopropane-1-carboxamide | | Formula: | C19 H21 F N8 O2 | | SMILES: | N(c1cnn(CCO)c1)c2nc(c(cn2)F)N4CC3C(C3)(C4)NC(C5C(C5)C#N)=O | | InChi: | InChI=1S/C19H21FN8O2/c20-15-7-22-18(24-13-6-23-28(9-13)1-2-29)25-16(15)27-8-12-4-19(12,10-27)26-17(30)14-3-11(14)5-21/h6-7,9,11-12,14,29H,1-4,8,10H2,(H,26,30)(H,22,24,25)/t11-,12+,14+,19+/m0/s1 | | Definition date: | 2020-01-30 | | Last modified: | 2020-04-03 | | Release date: | 2020-04-08 | | Identifier: | (1R,2R)-2-cyano-N-[(1S,5R)-3-(5-fluoro-2-{[1-(2-hydroxyethyl)-1H-pyrazol-4-yl]amino}pyrimidin-4-yl)-3-azabicyclo[3.1.0]hexan-1-yl]cyclopropane-1-carboxamide |
|
 | | R7V | | Name: | (1R,3S,4R)-4-[(3aR,9bR)-9b-[(4-fluorophenyl)sulfonyl]-7-(1,1,1,2,3,3,3-heptafluoropropan-2-yl)-1,2,3a,4,5,9b-hexahydro-3H-benzo[e]indole-3-carbonyl]-3-methylcyclohexane-1-carboxylic acid | | Formula: | C30 H29 F8 N O5 S | | SMILES: | c1c(cc2c(c1)C3(C(CC2)N(CC3)C(=O)C4CCC(CC4C)C(O)=O)S(c5ccc(cc5)F)(=O)=O)C(C(F)(F)F)(F)C(F)(F)F | | InChi: | InChI=1S/C30H29F8NO5S/c1-16-14-18(26(41)42)2-9-22(16)25(40)39-13-12-27(45(43,44)21-7-5-20(31)6-8-21)23-10-4-19(15-17(23)3-11-24(27)39)28(32,29(33,34)35)30(36,37)38/h4-8,10,15-16,18,22,24H,2-3,9,11-14H2,1H3,(H,41,42)/t16-,18+,22+,24+,27+/m0/s1 | | Definition date: | 2020-02-06 | | Last modified: | 2020-04-03 | | Release date: | 2020-04-08 | | Identifier: | (1R,3S,4R)-4-[(3aR,9bR)-9b-[(4-fluorophenyl)sulfonyl]-7-(1,1,1,2,3,3,3-heptafluoropropan-2-yl)-1,2,3a,4,5,9b-hexahydro-3H-benzo[e]indole-3-carbonyl]-3-methylcyclohexane-1-carboxylic acid |
|
 | | EVC | | Name: | N-ethyl-2-[[4-[[4-(4-methylpiperazin-1-yl)-3-(2-morpholin-4-ylethoxy)phenyl]amino]-1,3,5-triazin-2-yl]amino]benzenesulfonamide | | Formula: | C28 H39 N9 O4 S | | SMILES: | CCN[S](=O)(=O)c1ccccc1Nc2ncnc(Nc3ccc(N4CCN(C)CC4)c(OCCN5CCOCC5)c3)n2 | | InChi: | InChI=1S/C28H39N9O4S/c1-3-31-42(38,39)26-7-5-4-6-23(26)33-28-30-21-29-27(34-28)32-22-8-9-24(37-12-10-35(2)11-13-37)25(20-22)41-19-16-36-14-17-40-18-15-36/h4-9,20-21,31H,3,10-19H2,1-2H3,(H2,29,30,32,33,34) | | Definition date: | 2020-02-05 | | Last modified: | 2020-04-03 | | Release date: | 2020-04-08 | | Identifier: | ~{N}-ethyl-2-[[4-[[4-(4-methylpiperazin-1-yl)-3-(2-morpholin-4-ylethoxy)phenyl]amino]-1,3,5-triazin-2-yl]amino]benzenesulfonamide |
|
 | | EVL | | Name: | N-ethyl-2-[[4-[[3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]amino]-1,3,5-triazin-2-yl]amino]benzenesulfonamide | | Formula: | C28 H39 N9 O3 S | | SMILES: | CCN[S](=O)(=O)c1ccccc1Nc2ncnc(Nc3ccc(N4CCC(CC4)N5CCN(C)CC5)c(OC)c3)n2 | | InChi: | InChI=1S/C28H39N9O3S/c1-4-31-41(38,39)26-8-6-5-7-23(26)33-28-30-20-29-27(34-28)32-21-9-10-24(25(19-21)40-3)37-13-11-22(12-14-37)36-17-15-35(2)16-18-36/h5-10,19-20,22,31H,4,11-18H2,1-3H3,(H2,29,30,32,33,34) | | Definition date: | 2020-02-05 | | Last modified: | 2020-04-03 | | Release date: | 2020-04-08 | | Identifier: | ~{N}-ethyl-2-[[4-[[3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]amino]-1,3,5-triazin-2-yl]amino]benzenesulfonamide |
|